Ingalls & Snyder LLC Omeros Corp Transaction History
Ingalls & Snyder LLC
- $2.82 Billion
- Q2 2025
A detailed history of Ingalls & Snyder LLC transactions in Omeros Corp stock. As of the latest transaction made, Ingalls & Snyder LLC holds 3,982,913 shares of OMER stock, worth $16.6 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
3,982,913
Previous 3,977,813
0.13%
Holding current value
$16.6 Million
Previous $32.7 Million
63.46%
% of portfolio
0.42%
Previous 1.08%
Shares
32 transactions
Others Institutions Holding OMER
# of Institutions
139Shares Held
29.7MCall Options Held
383KPut Options Held
1.22M-
Black Rock Inc. New York, NY4.1MShares$17.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.28MShares$13.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.65MShares$6.89 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.52MShares$6.37 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.37MShares$5.73 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $262M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...